In cohorts of people with adult-onset diabetes and clinically diagnosed type 2 diabetes, the presence of autoantibodies and elevated type 1 diabetes genetic risk is associated with progression to insulin treatment, highlighting a likely misdiagnosis [75]. This evidence concerns the gene INS and type 2 diabetes mellitus.